BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Onoe S, Shimoyama Y, Ebata T, Yokoyama Y, Igami T, Sugawara G, Mizuno T, Nakamura S, Nagino M. Clinicopathological significance of mucin production in patients with papillary cholangiocarcinoma. World J Surg 2015;39:1177-84. [PMID: 25561191 DOI: 10.1007/s00268-014-2923-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
Number Citing Articles
1 Onoe S, Ebata T, Yokoyama Y, Igami T, Mizuno T, Yamaguchi J, Watanabe N, Otsuka S, Nakamura S, Shimoyama Y, Nagino M. A clinicopathological reappraisal of intraductal papillary neoplasm of the bile duct (IPNB): a continuous spectrum with papillary cholangiocarcinoma in 181 curatively resected cases. HPB (Oxford) 2021;23:1525-32. [PMID: 33832834 DOI: 10.1016/j.hpb.2021.03.004] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
2 Nakanuma Y, Uesaka K, Okamura Y, Terada T, Fukumura Y, Kakuda Y, Sugino T, Sato Y, Taek JK, Park YN. Reappraisal of pathological features of intraductal papillary neoplasm of bile duct with respect to the type 1 and 2 subclassifications. Hum Pathol 2021;111:21-35. [PMID: 33508254 DOI: 10.1016/j.humpath.2021.01.002] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
3 Nakanuma Y, Uesaka K, Kakuda Y, Sugino T, Kubota K, Furukawa T, Fukumura Y, Isayama H, Terada T. Intraductal Papillary Neoplasm of Bile Duct: Updated Clinicopathological Characteristics and Molecular and Genetic Alterations. J Clin Med 2020;9:E3991. [PMID: 33317146 DOI: 10.3390/jcm9123991] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 6.3] [Reference Citation Analysis]
4 Pabalan N, Sukcharoensin S, Butthongkomvong K, Jarjanazi H, Thitapakorn V. Expression and Serum Levels of Mucin 5AC (MUC5AC) as a Biomarker for Cholangiocarcinoma: a Meta-analysis. J Gastrointest Cancer 2019;50:54-61. [PMID: 29139058 DOI: 10.1007/s12029-017-0032-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
5 Li L, Knutsdottir H, Hui K, Weiss MJ, He J, Philosophe B, Cameron AM, Wolfgang CL, Pawlik TM, Ghiaur G, Ewald AJ, Mezey E, Bader JS, Selaru FM. Human primary liver cancer organoids reveal intratumor and interpatient drug response heterogeneity. JCI Insight 2019;4:121490. [PMID: 30674722 DOI: 10.1172/jci.insight.121490] [Cited by in Crossref: 80] [Cited by in F6Publishing: 83] [Article Influence: 20.0] [Reference Citation Analysis]
6 Kiriyama M, Ebata T, Yokoyama Y, Igami T, Sugawara G, Mizuno T, Yamaguchi J, Nagino M. Occult mucin-producing cholangiocarcinoma in situ: a rare clinical case with difficult tumour staging. Surg Case Rep 2017;3:6. [PMID: 28054282 DOI: 10.1186/s40792-016-0283-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]